Giulia Escobar

Milan, Italy

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications

Myeloid cell-based delivery of IFN-γ reprograms the leukemia microenvironment and induces anti-tumoral immune responses.

Myeloid cell-based delivery of IFN-γ reprograms the leukemia microenvironment and induces anti-tumoral immune responses.

Journal: EMBO molecular medicine
Published: October 16, 2020

Interferon gene therapy reprograms the leukemia microenvironment inducing protective immunity to multiple tumor antigens.

Interferon gene therapy reprograms the leukemia microenvironment inducing protective immunity to multiple tumor antigens.

Journal: Nature communications
Published: March 16, 2018

NY-ESO-1 TCR single edited stem and central memory T cells to treat multiple myeloma without graft-versus-host disease.

NY-ESO-1 TCR single edited stem and central memory T cells to treat multiple myeloma without graft-versus-host disease.

Journal: Blood
Published: August 06, 2016

IFNα gene/cell therapy curbs colorectal cancer colonization of the liver by acting on the hepatic microenvironment.

IFNα gene/cell therapy curbs colorectal cancer colonization of the liver by acting on the hepatic microenvironment.

Journal: EMBO molecular medicine
Published: January 16, 2016

Long-Pentraxin 3 Derivative as a Small-Molecule FGF Trap for Cancer Therapy.

Long-Pentraxin 3 Derivative as a Small-Molecule FGF Trap for Cancer Therapy.

Journal: Cancer cell
Published: July 31, 2014

Engineered tumor-infiltrating macrophages as gene delivery vehicles for interferon-α activates immunity and inhibits breast cancer progression.

Engineered tumor-infiltrating macrophages as gene delivery vehicles for interferon-α activates immunity and inhibits breast cancer progression.

Journal: Oncoimmunology
Published: March 17, 2014

Genetic engineering of hematopoiesis for targeted IFN-α delivery inhibits breast cancer progression.

Genetic engineering of hematopoiesis for targeted IFN-α delivery inhibits breast cancer progression.

Journal: Science translational medicine
Published: January 03, 2014

Targeted genome editing in human repopulating haematopoietic stem cells.

Targeted genome editing in human repopulating haematopoietic stem cells.

Journal: Nature
Published: August 02, 2013
Showing 1-8 of 8

Last Updated: 09/26/2026